CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Clinical trials for CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA explained in plain language.
Never miss a new study
Get alerted when new CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA trials appear
Sign up with your email to follow new studies for CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of gene therapy for deadly heart rhythm disorder
Disease control Recruiting nowThis is an early safety study testing a single dose of an experimental gene therapy called SGT-501 in people with CPVT, a rare inherited condition that causes dangerous fast heart rhythms during exercise or stress. The main goal is to see if the treatment is safe and tolerable in…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE1 • Sponsor: Solid Biosciences Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New pill aims to tame deadly Stress-Induced heart condition
Disease control Recruiting nowThis study is testing a new oral drug called AGP100 for people with a serious inherited heart condition called CPVT. CPVT causes the heart to beat dangerously fast during physical or emotional stress, even with current medications. The trial will check if AGP100 is safe and if it…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE2 • Sponsor: Agiana Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New hope for controlling sudden, Stress-Induced heart rhythms
Disease control Recruiting nowThis study is testing an investigational drug called CRD-4730 for adults with a rare inherited heart condition called CPVT, which causes dangerous fast heart rhythms during exercise or stress. The main goals are to see if the drug is safe and how the body processes it. Participan…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Brazil launches national hunt for genetic causes of heart disease
Knowledge-focused Recruiting nowThis study aims to create a national registry of Brazilian patients with inherited heart conditions to better understand their genetic causes. Researchers will collect health information and DNA samples from 600 participants during their regular doctor visits. The goal is to iden…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Sponsor: Hospital do Coracao • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC